Mohamed Barakat Khalil

Department of Clinical Oncology, Tanta University, Egypt

Publications

• Research Article   
  SIB-IMRT radiotherapy concomitant with cisplatin in locally advanced hypopharyngeal cancer: safety, feasibility
  Author(s): Lamiss Mohamed Sad*, Mohamed Barakat Khalil and Rasha Abd El-Ghany Khedr
  
  Introduction: Radiotherapy is the main line of treatment of head and neck cancer including hypopharyngeal cancer either adjuvant/neoadjuvant radiotherapy or neoadjuvant/adjuvant concurrent chemoradiotherapy. The aim of radiotherapy is to provide maximum safe dose to organ at risk (healthy normal tissues). Studies had shown that the need to increase dose to the tumour was associated with great hazard to healthy normal tissues with induction of acute and late toxicity. The acute toxicity will result in treatment breaks and decreased local control due to repopulation of the tumour cells especially in head and neck cancer. Aim of the study: It was to reduce the radiation dose received by critical normal organs to allowed tolerance. Materials and methods: Twenty-two hypopharyngeal cancer patients either receiving radiotherapy as definitive therapy with concurrent cisplatin in dose of 40 mg.. Read More»
  

  Abstract HTML PDF